Daljnoseni potencial zdravil GLP-1 bi lahko spremenil nain obvladovanja kroninih bolezni
Concretely, tobacco smoking, alcohol consumption, unbalanced diet, low fitness, increased BMI as well as unhealthy environmental influences are the key risk factors for the development of T2DM, and this form accounts for 96% of all DM cases [6]
Market Access Strategies and Pharmaceutical Innovations in Diabetes Care and Obesity Drug Market Securing market access remains a complex challenge for pharmaceutical companies
With glutathione therapy, the antioxidant capacity of our body is increased, making us more resistant to diseases
CHIP, derived from aging-related somatic mutations in hematopoietic stem and progenitor cells (HSPCs), increases susceptibility to chronic inflammatory diseases including periodontitis, AS and RA (169, 170)